Gilead eyes new deals from a 'position of strength'
|
Still riding the high of last year's twice-yearly HIV
PrEP approval of lenacapavir as Yeztugo, Gilead Sciences is approaching
dealmaking from a ... |
Top 10 counties in new HIV infections
In 2024, Kenya witnessed a concerning rise in new HIV infections, with the total number increasing by 19% from 16752 cases in 2023 to 19991. View article...